Format

Send to:

Choose Destination
See comment in PubMed Commons below
Neuropsychopharmacology. 2015 Oct;40(11):2510-6. doi: 10.1038/npp.2015.86. Epub 2015 Mar 24.

NCAN Cross-Disorder Risk Variant Is Associated With Limbic Gray Matter Deficits in Healthy Subjects and Major Depression.

Author information

  • 1Department of Psychiatry, University of Marburg, Marburg, Germany.
  • 2Department of Psychiatry, University of Münster, Münster, Germany.
  • 3Department of Clinical Radiology, University of Münster, Münster, Germany.
  • 4Department of Psychosomatic Medicine, University of Leipzig, Leipzig, Germany.
  • 5Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia.
  • 6Department of Psychiatry, University of Würzburg, Würzburg, Germany.
  • 7Institute of Human Genetics, University of Bonn, Bonn, Germany.
  • 8Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany.
  • 9Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany.

Abstract

Genome-wide association studies have reported an association between NCAN rs1064395 genotype and bipolar disorder. This association was later extended to schizophrenia and major depression. However, the neurobiological underpinnings of these associations are poorly understood. NCAN is implicated in neuronal plasticity and expressed in subcortical brain areas, such as the amygdala and hippocampus, which are critically involved in dysfunctional emotion processing and regulation across diagnostic boundaries. We hypothesized that the NCAN risk variant is associated with reduced gray matter volumes in these areas. Gray matter structure was assessed by voxel-based morphometry on structural MRI data in two independent German samples (healthy subjects, n=512; depressed inpatients, n=171). All participants were genotyped for NCAN rs1064395. Hippocampal and amygdala region-of-interest analyses were performed within each sample. In addition, whole-brain data from the combined sample were analyzed. Risk (A)-allele carriers showed reduced amygdala and hippocampal gray matter volumes in both cohorts with a remarkable spatial overlap. In the combined sample, genotype effects observed for the amygdala and hippocampus survived correction for entire brain volume. Further effects were also observed in the left orbitofrontal cortex and the cerebellum/fusiform gyrus. We conclude that NCAN genotype is associated with limbic gray matter alterations in healthy and depressed subjects in brain areas implicated in emotion perception and regulation. The present data suggest that NCAN forms susceptibility to neurostructural deficits in the amygdala, hippocampus, and prefrontal areas independent of disease, which might lead to disorder onset in the presence of other genetic or environmental risk factors.

PMID:
25801500
[PubMed - in process]
PMCID:
PMC4569958
[Available on 2016-10-01]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk